Linear IgA bullous dermatosis (LABD) is an autoimmune disease that causes blisters. People with LABD can develop blisters in the skin and the mucous membranes in their mouth, genitals, and eyelids.

Actually, there are several warning signs for biotechnology bulls, but the focus here is on the Direxion Daily S&P Biotech Bear 3X Shares (NYSE: LABD). The newly minted Direxion Daily S&P Biotech Bear ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Among leveraged and inverse biotechnology exchange-traded funds, the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) and the Direxion Daily S&P Biotech Bear 3X Shares (NYSE: LABD) are the ...

The Direxion Daily S&P Biotech Bear 3X Shares ETF offers -3X daily leverage to the S&P Biotechnology Select Industry Index, primarily attracting short-term traders. LABD has lost 99.98% of its value ...

Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the Direxion Daily S&P Biotech Bear 3X Shares, where 4,050,000 ...

The Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA: LABU) and Direxion Daily S&P Biotech Bear 3X Shares (NYSEARCA: LABD) ETFs have their place in a trading strategy. They can even be used as very ...

After a third-quarter swoon that saw the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) and the SPDR S&P Biotech ETF (NYSE: XBI), two of the largest biotech exchange traded funds by assets, tumble ...

Direxion Daily S&P Biotech Bear 3X Shares has no upcoming dividends reported. The last reported dividend for Direxion Daily S&P Biotech Bear 3X Shares (LABD) was $0.03 and was paid out on September 30 ...

No news for LABD in the past two years. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed ...